Deregulated or elevated expression of c-MYC has been documented in a wide range of human malignancies and is often associated with tumours of an aggressive, poorly differentiated phenotype (Dang, 1999; Nesbit et al, 1999). This evidence concerns the gene MYC and neoplasm.